<SEC-DOCUMENT>0001104659-22-112458-index.html : 20221028 <SEC-HEADER>0001104659-22-112458.hdr.sgml : 20221028 <ACCEPTANCE-DATETIME>20221028161838 ACCESSION NUMBER: 0001104659-22-112458 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20221028 DATE AS OF CHANGE: 20221028 EFFECTIVENESS DATE: 20221028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-268051 FILM NUMBER: 221342141 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tm2229174d1_s8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: tm2229174d1_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2229174d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2229174d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tm2229174d1_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: tm2229174d1_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>tm2229174d1_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: tm2229174d1_ex-filingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2229174d1_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2229174d1_ex5-1img001.jpg
</DOCUMENT> </SEC-DOCUMENT>